deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00801281

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. (PLRG4)

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.A Multicentre, Phase III Randomized Study by the PLRG.

Sponsor: Polish Lymphoma Research Group

Conditions Follicular Lymphoma Lymphoplasmacytic Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma
Interventions Cyclophosphamide Doxorubicin Prednisone 1 Prednisone 2 Rituximab Vincristine
Updated 7 times since 2017 Last updated: Jul 12, 2017 Started: Feb 28, 2007 Primary completion: Jun 25, 2017 Completion: Jun 25, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00801281, this PHASE3 trial focuses on Follicular Lymphoma and Lymphoplasmacytic Lymphoma and remains completed. Sponsored by Polish Lymphoma Research Group, it has been updated 7 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotActive Not Recruiting~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Aug 2017 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  2. Jan 2017 — Aug 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Polish Lymphoma Research Group
Data source: Polish Lymphoma Research Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations